Print Print page | E-mail E-mail page

Media

Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.

  Click here to download our most recent fact sheet.

= Add Release to Briefcase
All Releases
View Summary Corgentech Plans Meeting With FDA to Discuss Registration Strategy Prior to Unblinding of Phase 3 Trial
Feb 24, 2005
PDF 68.5 KB Add to Briefcase
View Summary Corgentech Announces Fourth Quarter and Year-End 2004 Financial Results
Feb 3, 2005
PDF 82.5 KB Add to Briefcase
View Summary Corgentech to Announce Fourth Quarter and Year-End 2004 Financial Results and Host Webcast Conference Call on February 3, 2005
Feb 1, 2005
PDF 69.8 KB Add to Briefcase
View Summary Corgentech to Present at 17th Annual Piper Jaffray Health Care Conference
Jan 20, 2005
PDF 63.9 KB Add to Briefcase
View Summary Corgentech Files Investigational New Drug Application to Begin Phase 1/2 Trial of New Drug Candidate for Eczema
Jan 12, 2005
PDF 70.8 KB Add to Briefcase
Showing 111-115 of 161 releases Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33  See Previous 5 | See Next 5

MEDIA CONTACTS

Paul Goodson
Sr. Director, Investor Relations
Anesiva, Inc.
Phone: 650-246-6898
Fax: 650-624-7540
[email protected]

Daryl Messinger
WeissComm Partners
Phone: 415-999-2361